Overview

Healthcare Distribution Services Market is poised to register a CAGR of 6.5% during the forecast period 2022 to 2028.

Healthcare distribution is described as the notion of providing patients with various care services such as medications, diagnostic tests, and other facilities. The healthcare system is quite beneficial since it assists individuals in staying healthy. Some of the most frequent forms of healthcare distribution include pharmaceutical product distribution, medical device distribution service, and biopharmaceutical distribution service. Many various technologies and advances are being used by the healthcare business to expand the industry and give better amenities to patients.

The distribution network is critical in the supply chain because it ensures that pharmaceuticals reach customers. A drug's distribution is a vital component of its economic success. To distribute medications, a sophisticated process including several restrictions must be followed. In established economies like as the United States, a few major wholesalers dominate the wholesale industry, selling to regional wholesalers and/or drugstore chains. In most underdeveloped nations, however, drug distribution is a difficult and fragmented industry. Small wholesalers and the lack of established retail chains complicate the procedure in these nations. Healthcare distribution refers to the provision of various care services to patients, such as medications, diagnostic tests, and other facilities.

The healthcare system is extremely beneficial since it keeps people healthy. Some of the most frequent kinds of healthcare distribution are pharmaceutical distribution, medical device distribution, and biopharmaceutical distribution. Many various technologies and advances are being used to enhance the healthcare business and provide better patient care. Today, pharmaceutical merchants are stepping up their efforts to ensure the correct distribution of pharmaceutical items. By supplying healthcare supplies and services in a secure and efficient manner, they are also contributing to patient security. Pharmaceutical commodities are kept and delivered from manufacturing plants to wholesalers, patients, or hospitals in the healthcare distribution sector.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Healthcare Distribution Services Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Healthcare Distribution Services Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Key players that dominate the market includes 
FFF Enterprises, Owens & Minor, Inc., McKesson Corporation, Mutual Drug, CuraScript SD, Rochester Drug Cooperative, Inc.,  Medline Industries, Patterson Companies Inc., AmerisourceBergen Corporation, Morris and Dickson Co., LLC, Henry Schein Inc., Smith Drug Company.

Healthcare Distribution Services Market Segmentation:

By Type

• Pharmaceutical Product Distribution Services
  o Over-The-Counter Drugs/Vitamins
  o Brand-Name/Innovator Drugs
  o Technology Collaborations
  o Generic Drugs
  o Strategic Divestments
• Medical Device Distribution Services
• Biopharmaceutical Product Distribution Services
  o Joint Ventures
  o Mergers and Acquisitions
  o Licensing and Partnership
  o Technology Collaborations
  o Strategic Divestments

By End User

• Retail Pharmacies
• Hospital Pharmacies
• Other End Users

By Region

• Europe
• North America
• Asia Pacific
• Latin America
• Middle East and Africa

Healthcare Distribution Services Market Sample Video:

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the market by type, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, industry-specific restraints and opportunities)
• To forecast and evaluate micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
• To record , evaluate and analyze competitive landscape mapping- technological advancements, product launches, expansions and mergers

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
         1.1. Objectives of the Study 
         1.2. Market Definition 
         1.3. Market Scope 
                1.3.1. Years Considered for the Study
                1.3.2. Market Covered
         1.4. Currency 
         1.5. Limitations 
         1.6. Stakeholders 
 2.  Research Methodology 
         2.1. Research Data 
                2.1.1. Secondary Data
                           2.1.1.1. Key Data from Secondary Sources
                2.1.2. Primary Data
                           2.1.2.1. Key Data from Primary Sources
         2.2. Market Size Estimation 
         2.3. Market Breakdown and Data Triangulation 
         2.4. Assumptions for the Study  
3. Executive Summary
         3.1. Market Outlook
         3.2. Segment Outlook
         3.3. Competitive Insights
4. Healthcare Distribution Services Market Variables, Trends & Scope
         4.1. Market Lineage Outlook
         4.2. Penetration and Growth Prospect Mapping
         4.3. Industry Value Chain Analysis
         4.4. Cost Analysis Breakdown
         4.5. Technology Overview
         4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Healthcare Distribution Services Market Overview
         5.1. Market Dynamics
                 5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Healthcare Distribution Services Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                 5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                 5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Healthcare Distribution Services Market Analysis Tools
         6.1. Industry Analysis - Porter’s
                 6.1.1. Supplier Power
                 6.1.2. Buyer Power
                 6.1.3. Substitution Threat
                 6.1.4. Threat from New Entrants
                 6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
                 6.2.1. Political Landscape
                 6.2.2. Environmental Landscape
                 6.2.3. Social Landscape
                 6.2.4. Technology Landscape
                 6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                 6.3.1. Joint Ventures
                 6.3.2. Mergers and Acquisitions
                 6.3.3. Licensing and Partnership
                 6.3.4. Technology Collaborations
                 6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies
7. Healthcare Distribution Services Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
         7.1. Pharmaceutical Product Distribution Services
                 7.1.1. OTC Drugs/Vitamins
                 7.1.2. Generic Drugs
                 7.1.3. Brand-name/Innovator Drugs
                 7.1.4. Technology Collaborations
                 7.1.5. Strategic Divestments
         7.2. Medical Device Distribution Services
         7.3. Biopharmaceutical Product Distribution Services
                 7.3.1. Joint Ventures
                 7.3.2. Mergers and Acquisition
                 7.3.3. Licensing and Partnership
                 7.3.4. Technology Collaborations
                 7.3.5. Strategic Divestments
8. Healthcare Distribution Services Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
         8.1. Retail Pharmacies
         8.2. Hospital Pharmacies
         8.3. Other
9. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
         9.1. Introduction
         9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                 9.2.1. U.S.A
                 9.2.2. Canada
                 9.2.3. Mexico
         9.3. Market Size (USD Million) Forecast for North America 2022-2028 
10. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
         10.1. Introduction
         10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                   10.2.1. Brazil
                   10.2.2. Venezuela
                   10.2.3. Argentina
                   10.2.4. Rest of Latin America
         10.3. Market Size (USD Million) Forecast for Latin America 2022-2028  
11. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
         11.1. Introduction
         11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                   11.2.1. Germany
                   11.2.2. U.K
                   11.2.3. France
                   11.2.4. Italy
                   11.2.5. Spain
                   11.2.6. Russia
                   11.2.7. Poland
                   11.2.8. Rest of Europe
         11.3. Market Size (USD Million) Forecast for Europe 2022-2028
12. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
         12.1. Introduction
         12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                   12.2.1. Japan
                   12.2.2. China
                   12.2.3. India
                   12.2.4. Australia and New Zealand
                   12.2.5. ASEAN
                   12.2.6. Rest of Asia Pacific
         12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
13. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
         13.1. Introduction
         13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                   13.2.1. GCC
                   13.2.2. Israel
                   13.2.3. South Africa
                   13.2.4. Rest of MEA
         13.3. Market Size (USD Million) Forecast for MEA 2022-2028
14. Market Share Analysis and Competitive Landscape   
    14.1. Global Landscape - Key Players, Revenue and Presence
    14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    14.3. Global Emerging Companies
    14.4. North America - Market Share Analysis and Key Regional Players
    14.5. Europe - Market Share Analysis and Key Regional Players
    14.6. Asia Pacific - Market Share Analysis and Key Regional Players
    14.7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
         15.1. FFF Enterprises 
                   15.1.1. Company Overview
                   15.1.2. Product Portfolio
                   15.1.3. SWOT Analysis
                   15.1.4. Financial Overview
                   15.1.5. Strategic Overview
         15.2. Owens & Minor, Inc.
                   15.2.1. Company Overview
                   15.2.2. Product Portfolio
                   15.2.3. SWOT Analysis
                   15.2.4. Financial Overview
                   15.2.5. Strategic Overview
         15.3. McKesson Corporation
                   15.3.1. Company Overview
                   15.3.2. Product Portfolio
                   15.3.3. SWOT Analysis
                   15.3.4. Financial Overview
                   15.3.5. Strategic Overview
         15.4. Mutual Drug
                   15.4.1. Company Overview
                   15.4.2. Product Portfolio
                   15.4.3. SWOT Analysis
                   15.4.4. Financial Overview
                   15.4.5. Strategic Overview
         15.5. CuraScript SD
                   15.5.1. Company Overview
                   15.5.2. Product Portfolio
                   15.5.3. SWOT Analysis
                   15.5.4. Financial Overview
                   15.5.5. Strategic Overview
         15.6. Rochester Drug Cooperative, Inc.
                   15.6.1. Company Overview
                   15.6.2. Product Portfolio
                   15.6.3. SWOT Analysis
                   15.6.4. Financial Overview
                   15.6.5. Strategic Overview
         15.7 Medline Industries
                   15.7.1. Company Overview
                   15.7.2. Product Portfolio
                   15.7.3. SWOT Analysis
                   15.7.4. Financial Overview
                   15.7.5. Strategic Overview
         15.8. Patterson Companies Inc.
                   15.8.1. Company Overview
                   15.8.2. Product Portfolio
                   15.8.3. SWOT Analysis
                   15.8.4. Financial Overview
                   15.8.5. Strategic Overview
         15.9. AmerisourceBergen Corporation
                   15.9.1. Company Overview
                   15.9.2. Product Portfolio
                   15.9.3. SWOT Analysis
                   15.9.4. Financial Overview
                   15.9.5. Strategic Overview
         15.10. Morris and Dickson Co.
                   15.10.1. Company Overview
                   15.10.2. Product Portfolio
                   15.10.3. SWOT Analysis
                   15.10.4. Financial Overview
                   15.10.5. Strategic Overview
         15.11. Henry Schein Inc.
                   15.11.1. Company Overview
                   15.11.2. Product Portfolio
                   15.11.3. SWOT Analysis
                   15.11.4. Financial Overview
                   15.11.5. Strategic Overview
         15.12. Smith Drug Company
                   15.12.1. Company Overview
                   15.12.2. Product Portfolio
                   15.12.3. SWOT Analysis
                   15.12.4. Financial Overview
                   15.12.5. Strategic Overview
16. Pre and Post COVID-19 Impact
    16.1. Positive influence on the healthcare industry
    16.2. The financial disruption of the manufacturing sector
    16.3. Impact of COVID-19 on emerging companies
    16.4. Significant mandates in the healthcare regulations initiated by administrations
    16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client

Tables

Figures